CCL2 and familial pancreatic carcinoma: Despite oncogenic role of MCP-1 was reported [9,10,17], pancreatic cancer patients with high circulating levels of MCP-1 demonstrated significantly higher survival rate than do those with low MCP-1 levels [26].